Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study.
Prativa SubediGopal Kumar YadavBinod PaudelAnu RegmiPrajjwal PyakurelPublished in: PloS one (2021)
More than two-third of the vaccinees developed one or more forms of adverse events, but most events were self-limiting. Females and young adults were more prone to develop AEFI.